Abstract
This presentation reviews data from epidemiologic and clinical trials on antioxidant vitamins, angiotensin-converting enzyme inhibitors, and homocysteine and their effect on atherosclerotic cardiovascular disease. Each of these areas seems promising, but the results of large, on-going studies must be determined before definitive conclusions can be made as to the effectiveness of these therapies.
MeSH terms
-
Adult
-
Aged
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Ascorbic Acid / therapeutic use
-
Cohort Studies
-
Coronary Artery Disease / epidemiology
-
Coronary Artery Disease / physiopathology
-
Coronary Artery Disease / prevention & control*
-
Female
-
Homocysteine / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Oxidative Stress
-
Randomized Controlled Trials as Topic
-
Vitamin E / therapeutic use
-
beta Carotene / therapeutic use
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
beta Carotene
-
Homocysteine
-
Vitamin E
-
Ascorbic Acid